A carregar...
Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression
Glioblastoma (GBM) is the most common and aggressive of all brain tumors, with a median survival of only 14 months after initial diagnosis. Novel therapeutic approaches are an unmet need for GBM treatment. MicroRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression at the p...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6210372/ https://ncbi.nlm.nih.gov/pubmed/30322013 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers10100382 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|